Amicus Therapeutics Inc. logo

Amicus Therapeutics Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

12.32
 
USD
  
0.26
  
(2.16%)
Optionable: Yes  Market Cap: 3,467 M  90-day average vol: 3,366,301

Previous close: 12.06  Open: 12.15  Bid: 12.44  Ask: 12.44
52 week range    
5.91   
   12.76
Peers   
BIIB / 
GSK / 
ESPR / 
BMRN / 
NVO / 
Last updated: Sunday 14th August 2022
52
MarketXLS Rank marketxls
45
Value marketxls
53
Technical marketxls
60
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BIIB

34 B21.6221.3

BMRN

16 B886.389.37

ESPR

0 B-0.43.42

GSK

LXRX

0 B-6.73.1

NVO

Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 18.157


Financials

FOLD Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues18 M3630001 M05 M37 M91 M182 M261 M306 M
Cost of sales-2 M-2 M-2 M-2 M-2 M3 M10 M17 M22 M28 M
Gross operating profit18 M3630001 M04 M31 M77 M160 M230 M271 M
Selling Gen & administrative expense19 M19 M21 M47 M71 M89 M127 M170 M156 M193 M
Research & development expense50 M42 M48 M77 M105 M149 M271 M286 M308 M272 M
Operating income-53 M-62 M-69 M-126 M-175 M-211 M-325 M-301 M-244 M-200 M
floaterest income0000000000
floaterest expense0000000000
Other income net674000-1 M-114000-5 M-25 M-225 M-12 M-47 M-11 M-10 M
Pre-tax Income (EBT)-52 M-63 M-70 M-132 M-204 M-449 M-349 M-356 M-274 M-242 M
Income taxes-3 M-4 M-1 M0-4 M-165 M-940004780003 M9 M
Net income from total operations-49 M-60 M-69 M-132 M-200 M-284 M-349 M-356 M-277 M-250 M
Minority floaterest0000000000
Total net income-49 M-60 M-69 M-132 M-200 M-284 M-349 M-356 M-277 M-250 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-49 M-60 M-69 M-132 M-200 M-284 M-349 M-356 M-277 M-250 M
Depreciation2 M2 M2 M2 M3 M4 M4 M5 M9 M6 M
Amortization0000000000
Operating income before depreciation (EBITDA)-50 M-61 M-67 M-129 M-195 M-428 M-322 M-332 M-243 M-203 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-1.07-1.16-0.93-1.2-1.49-1.85-1.88-1.48-1.07-0.92
Diluted EPS total-1.07-1.16-0.93-1.2-1.49-1.85-1.88-1.48-1.07-0.92
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!